The merged entity will continue to use the current brand name Max Healthcare with appropriate adjustments to its logo.
Read More
The moves come after the World Health Organization paused its large trial of hydroxychloroquine after the British journal The Lancet reported patients getting the drug had increased death rates and irregular heartbeats.
Read More
The University of Tokyo had announced plans for a trial of nafamostat and camostat mesilate, a related drug, starting as early as April 2020.
Read More
The expanded agreement with pharmaceutical ingredient supplier CordenPharma will be effective immediately to help meet its increasing demand over the coming months
Read More
GSK is working on its own COVID vaccine with French drugmaker Sanofi, one of the many projects to counter the respiratory illness that currently that has no treatment and has killed about 350,000 people.
Read More
Patanjali Ayurved acquired the bankrupt Ruchi Soya for Rs 4,350 crore, maker of soya food brand Nutrela, through an insolvency process.
Read More
Sanofi is selling the Regeneron shares at $515.00 per share - a discount of around 5.5% to Regeneron's closing price of $545.21 on May 26, and raising gross proceeds of $11.1 billion.
Read More
Roche Chief Executive Severin Schwan is looking beyond cancer drugs to fresh treatment areas, while Novartis CEO Vas Narashiman bulks up in the same territory.
Read More
